Laurion Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,055,498
Closed -$204M 1377
2019
Q3
$204M Buy
2,055,498
+1,237,394
+151% +$118M 1.52% 11
2019
Q2
$75.6M Buy
818,104
+194,900
+31% +$18.5M 0.74% 31
2019
Q1
$58.8M Buy
623,204
+534,059
+599% +$46.7M 0.79% 23
2018
Q4
$5.71M Sell
89,145
-141,727
-61% -$10.5M 0.1% 255
2018
Q3
$20.7M Buy
230,872
+175,203
+315% +$15.5M 0.2% 105
2018
Q2
$4.42M Sell
55,669
-15,200
-21% -$1.26M 0.04% 383
2018
Q1
$6.32M Sell
70,869
-15,265
-18% -$1.47M 0.05% 316
2017
Q4
$8.99M Buy
86,134
+83,834
+3,645% +$9.46M 0.05% 376
2017
Q3
$335K Sell
2,300
-12,800
-85% -$1.74M ﹤0.01% 1305
2017
Q2
$1.96M Buy
+15,100
New +$1.85M 0.01% 815
2017
Q1
Sell
-1,800
Closed -$215K 1748
2016
Q4
$208K Sell
1,800
-800
-31% -$89.1K ﹤0.01% 997
2016
Q3
$272K Buy
+2,600
New +$281K ﹤0.01% 739

Other funds holding CELG

Laurion Capital Management's CELG Position: Q4 2019 in Review

Laurion Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,055,498 shares — an estimated $204M sold.

Laurion Capital Management first reported a position in CELG in Q3 2016 and held it in 12 quarters. The position peaked at $204M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Laurion Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Laurion Capital Management sold 2,055,498 Celgene Corp shares in Q4 2019, an estimated $204M.
  • Laurion Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 12 quarters.
  • Laurion Capital Management's Celgene Corp position peaked at $204M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Laurion Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.